S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Completed · Phase 3 · Has a placebo group
Conditions studied: Bladder Cancer
In brief
RATIONALE: Drugs used in chemotherapy, such as gemcitabine, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving gemcitabine directly into the bladder after surgery may kill more tumor cells. It is not yet known whether giving gemcitabine directly into the bladder is more effective than a placebo in treating bladder cancer. PURPOSE: This randomized phase III trial is studying gemcitabine to see how well it works when given directly into the bladder compared with a placebo after surgery in treating patients with newly diagnosed or recurrent bladder cancer.
Key facts
- Study ID
- NCT00445601
- Run by
- SWOG Cancer Research Network
- People needed
- 406
- Starts
- 2007-09-01
- Expected to finish
- 2017-06-01
- Last updated by the study team
- 2020-01-18
Who can join
Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center — Los Angeles, California, United States
- University of California Davis Cancer Center — Sacramento, California, United States
- University of Colorado Cancer Center at UC Health Sciences Center — Aurora, Colorado, United States
- Urology Center of Colorado — Denver, Colorado, United States
- Veterans Affairs Medical Center - Denver — Denver, Colorado, United States
- St. Joseph Regional Medical Center — Lewiston, Idaho, United States
- Cardinal Bernardin Cancer Center at Loyola University Medical Center — Maywood, Illinois, United States
- St. Rose Ambulatory and Surgery Center — Great Bend, Kansas, United States
- Hays Medical Center — Hays, Kansas, United States
- Hutchinson Hospital Corporation — Hutchinson, Kansas, United States
- Kansas City Cancer Centers - West — Kansas City, Kansas, United States
- Kansas Masonic Cancer Research Institute at the University of Kansas Medical Center — Kansas City, Kansas, United States
- Kansas City Cancer Centers - Southwest — Overland Park, Kansas, United States
- Mount Carmel Regional Cancer Center — Pittsburg, Kansas, United States
- Tammy Walker Cancer Center at Salina Regional Health Center — Salina, Kansas, United States
- Kansas City Cancer Center - Shawnee Mission — Shawnee Mission, Kansas, United States
- St. Francis Comprehensive Cancer Center — Topeka, Kansas, United States
- Feist-Weiller Cancer Center at Louisiana State University Health Sciences — Shreveport, Louisiana, United States
- University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan, United States
- Josephine Ford Cancer Center at Henry Ford Hospital — Detroit, Michigan, United States
- William Beaumont Hospital - Royal Oak Campus — Royal Oak, Michigan, United States
- Truman Medical Center - Hospital Hill — Kansas City, Missouri, United States
- Veterans Affairs Medical Center - Kansas City — Kansas City, Missouri, United States
- Kansas City Cancer Centers - South — Kansas City, Missouri, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences — Little Rock, Arkansas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.